These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11434575)

  • 1. Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus.
    Bae SC; Koh HK; Chang DK; Kim MH; Park JK; Kim SY
    Lupus; 2001; 10(6):405-9. PubMed ID: 11434575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus.
    Liang MH; Socher SA; Larson MG; Schur PH
    Arthritis Rheum; 1989 Sep; 32(9):1107-18. PubMed ID: 2775320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians.
    Chang E; Abrahamowicz M; Ferland D; Fortin PR;
    J Clin Epidemiol; 2002 May; 55(5):488-97. PubMed ID: 12007552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do lupus disease activity measures detect clinically important change?
    Fortin PR; Abrahamowicz M; Clarke AE; Neville C; Du Berger R; Fraenkel L; Liang MH
    J Rheumatol; 2000 Jun; 27(6):1421-8. PubMed ID: 10852264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity.
    Chang ER; Abrahamowicz M; Ferland D; Fortin PR
    J Rheumatol; 2002 Nov; 29(11):2350-8. PubMed ID: 12415591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus.
    Mattsson M; Möller B; Lundberg Ie; Gard G; Boström C
    Scand J Rheumatol; 2008; 37(4):269-77. PubMed ID: 18612927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties.
    Chessa E; Piga M; Floris A; Devilliers H; Cauli A; Arnaud L
    Rheumatology (Oxford); 2020 Dec; 59(12):3622-3632. PubMed ID: 32789462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
    Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
    J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients.
    FitzGerald JD; Grossman JM
    Lupus; 1999; 8(8):638-44. PubMed ID: 10568901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of systemic lupus erythematosus disease activity by medical record review compared with direct standardized evaluation.
    Wluka AE; Liang MH; Partridge AJ; Fossel AH; Wright EA; Lew RA; Karlson EW
    Arthritis Rheum; 1997 Jan; 40(1):57-61. PubMed ID: 9008600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and adaptation of the Spanish version of the systemic lupus activity questionnaire (S-SLAQ) in an Argentinean population.
    Catoggio C; Martínez Muñoz A; Chaparro Del Moral R; Klajn DS; Papasidero SB; Machado Escobar MA; Gonzalez Lucero L; Lucero E; Martinez L; Muñoz SA; Collado MV; Gomez GN; Sarano J; Marin J; Scolnik M; Romero J; Barreira JC; Zalazar MM; Rillo OL; Pisoni C
    Lupus; 2021 Dec; 30(14):2230-2236. PubMed ID: 34894851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rating scale preference measure as an evaluative measure in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    Lupus; 2000; 9(9):696-701. PubMed ID: 11199925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small changes in outpatients lupus activity are better detected by clinical instruments than by laboratory tests.
    Fortin PR; Abrahamowicz M; Danoff D
    J Rheumatol; 1995 Nov; 22(11):2078-83. PubMed ID: 8596148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
    Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
    Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of discordance between patients and physicians in their assessment of lupus disease activity.
    Yen JC; Abrahamowicz M; Dobkin PL; Clarke AE; Battista RN; Fortin PR
    J Rheumatol; 2003 Sep; 30(9):1967-76. PubMed ID: 12966600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.